Why the study?
The physiological mechanisms involved in augmented cholinergic agonist-induced sweating in exercise-trained individuals remain unclear.
Does nitric oxide synthase inhibition attenuate pilocarpine-induced sweating in exercise-trained men?
Does nitric oxide synthase inhibition attenuate pilocarpine-induced sweating in exercise-trained men?
Nitric oxide synthase partially contributes to the increased cholinergic sweating observed in exercise-trained men.
NOS inhibition attenuates sweating only in trained men; leaves open full mechanisms of training-induced cholinergic adaptations.
The physiological mechanisms involved in augmented cholinergic agonist-induced sweating in exercise-trained individuals remain unclear. This study hypothesizes that nitric oxide synthase (NOS) contributes to augmented pilocarpine-induced sweating in habitually exercise-trained individuals. Endurance-trained and untrained men ( n = 15 each) iontophoretically received 1% L-NAME, a NOS inhibitor, and saline (control) in the forearm and then administered 0.001% and 1% pilocarpine to evaluate sweat rate. L-NAME administration attenuated pilocarpine-induced sweating by 10% in the exercise-trained ( P = 0.004) but not in untrained ( P = 0.764) groups independent of pilocarpine concentrations. Results indicate that NOS partially contributes to increased cholinergic sweating in exercise-trained men.
No takes yet. Share an insight, caveat, or question.
Okamoto et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: